BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10464572)

  • 1. Genetic testing and Alzheimer disease: recommendations of the Stanford Program in Genomics, Ethics, and Society.
    McConnell LM; Koenig BA; Greely HT; Raffin TA
    Genet Test; 1999; 3(1):3-12. PubMed ID: 10464572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ethics of disclosing genetic diagnosis for Alzheimer's disease: do we need a new paradigm?
    Arribas-Ayllon M
    Br Med Bull; 2011; 100():7-21. PubMed ID: 21672937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Special issues in genetic testing for Alzheimer disease.
    Greely HT
    Genet Test; 1999; 3(1):115-9. PubMed ID: 10464585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surrogate decision making for genetic testing for Alzheimer disease.
    Eaton ML
    Genet Test; 1999; 3(1):93-7. PubMed ID: 10464582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic testing and Alzheimer disease: has the time come? Alzheimer Disease Working Group of the Stanford Program in Genomics, Ethics & Society.
    McConnell LM; Koenig BA; Greely HT; Raffin TA
    Nat Med; 1998 Jul; 4(7):757-9. PubMed ID: 9662356
    [No Abstract]   [Full Text] [Related]  

  • 7. The genetics of Alzheimer disease and the application of molecular tests.
    Tobin SL; Chun N; Powell TM; McConnell LM
    Genet Test; 1999; 3(1):37-45. PubMed ID: 10464576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical issues in genetic testing for Alzheimer's disease.
    Kahn J
    Geriatrics; 1997 Sep; 52 Suppl 2():S30-2. PubMed ID: 9307583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of medical decision analysis to genetic testing: an introduction.
    McConnell LM; Goldstein MK
    Genet Test; 1999; 3(1):65-70. PubMed ID: 10464579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding probabilistic risk in predisposition genetic testing for Alzheimer disease.
    Koenig BA; Silverberg HL
    Genet Test; 1999; 3(1):55-63. PubMed ID: 10464578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective.
    Post SG; Whitehouse PJ; Binstock RH; Bird TD; Eckert SK; Farrer LA; Fleck LM; Gaines AD; Juengst ET; Karlinsky H; Miles S; Murray TH; Quaid KA; Relkin NR; Roses AD; St George-Hyslop PH; Sachs GA; Steinbock B; Truschke EF; Zinn AB
    JAMA; 1997 Mar; 277(10):832-6. PubMed ID: 9052715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The psychological impact of genetic testing for Alzheimer disease.
    Coon DW; Davies H; McKibben C; Gallagher-Thompson D
    Genet Test; 1999; 3(1):121-31. PubMed ID: 10464586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical issues in ocular genetics.
    Mezer E; Wygnanski-Jaffe T
    Curr Opin Ophthalmol; 2009 Sep; 20(5):382-6. PubMed ID: 19587598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical principles and pitfalls of genetic testing for dementia.
    Hedera P
    J Geriatr Psychiatry Neurol; 2001; 14(4):213-21. PubMed ID: 11794449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies and ethical issues in cancer-genetics clinics.
    Harris M; Winship I; Spriggs M
    Lancet Oncol; 2005 May; 6(5):301-10. PubMed ID: 15863378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives in genetic prediction of Alzheimer's disease.
    Šerý O; Povová J; Balcar VJ
    Neuro Endocrinol Lett; 2014; 35(5):359-66. PubMed ID: 25275266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics, ethics, and Alzheimer disease.
    Post SG
    J Am Geriatr Soc; 1994 Jul; 42(7):782-6. PubMed ID: 8014357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians' legal duties regarding the use of genetic tests to predict and diagnose Alzheimer disease.
    Kapp MB
    J Leg Med; 2000 Dec; 21(4):445-75. PubMed ID: 11194569
    [No Abstract]   [Full Text] [Related]  

  • 19. Apolipoprotein E genotyping for Alzheimer's disease: ethical concerns and implications for clinical practice.
    Abyad A; al Imad R
    J Med Liban; 1999; 47(5):291-4. PubMed ID: 10887530
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of genetic tests: APOE genotyping for the diagnosis of Alzheimer disease.
    McConnell LM; Sanders GD; Owens DK
    Genet Test; 1999; 3(1):47-53. PubMed ID: 10464577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.